Unnatural Products Inc. notched another collaboration by signing on with Argenx SE in a multitarget research collaboration. Unnatural Products, which is getting up-front, near-term payments and R&D funding, could end up with about $1.5 billion in milestones and options payments plus tiered royalties on net sales. Read More
The joining of psychedelic specialists Beckley Psytech Ltd. and Atai Life Sciences can now go ahead after the pair announced positive top-line results from the phase IIb study of BPL-003, an intranasal formulation of 5-MeO-DMT benzoate. Read More
Torrent Pharmaceutical Ltd. will buy J. B. Chemicals and Pharmaceuticals Ltd. (JB Pharma) from private equity firm KKR & Co. Inc. at an equity valuation of ₹256.89 billion (US$3 billion), which will then merge into one entity under Torrent Pharma. Read More
While the first meeting of the U.S. CDC’s newly minted Advisory Committee for Immunization Practices (ACIP) is now recent history, questions about the makeup of the committee and its future direction remain unanswered. Read More
Taiwan’s Hanchorbio Inc. is out-licensing its breakthrough checkpoint inhibitor, HCB-101, to Shanghai Henlius Biotech Inc. in a deal worth more than $200 million. Read More
Hong Kong’s Department of Health (DH) announced plans to establish a new medical products regulatory agency called the Hong Kong Centre for Medical Products Regulation (CMPR) by the end of 2026. Read More
Without using the words “universal” or “nationwide,” a U.S. district judge granted a preliminary injunction July 1 to stop the Department of Health and Human Services’ (HHS) reorganization plan, along with any workforce reduction that’s part of the plan. Read More
BioWorld's newly launched index insights page provides an in-depth look at sector performance across six major indices. Get access to the latest index charts, top-performing companies and recent stories highlighting trends in the biopharma, drug developers, cancer, infectious disease and neurological sectors. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alto, AN2, Argenx, Artelo, Ashvattha, Aurinia, Biogen, Celcuity, Chemomab, Corbus, Hansa, Idorsia, Inmune, InvIos, Moderna, OS. Read More
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antev, Esteve, Mabwell, Medicus, Qilu, Sanofi. Read More
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hutchmed, Sanofi, Sobi, Takeda, Tempest. Read More
